Ibio (0JV0) Price & Analysis

Q: What was Ibio Inc’s price range in the past 12 months?

Ibio Inc lowest stock price was €0.44 and its highest was €3.51 in the past 12 months.

Q: What is Ibio Inc’s market cap?

Ibio Inc’s market cap is $22.57M.

Q: When is Ibio Inc’s upcoming earnings report date?

Ibio Inc’s upcoming earnings report date is Nov 18, 2025 which is in 6 days.

Q: How were Ibio Inc’s earnings last quarter?

Ibio Inc released its earnings results on Sep 05, 2025. The company reported -€0.276 earnings per share for the quarter, beating the consensus estimate of -€0.302 by €0.026.

Q: Is Ibio Inc overvalued?

According to Wall Street analysts Ibio Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: Does Ibio Inc pay dividends?

Ibio Inc does not currently pay dividends.

Q: What is Ibio Inc’s EPS estimate?

Ibio Inc’s EPS estimate is -0.18.

Q: How many shares outstanding does Ibio Inc have?

Ibio Inc has 20,254,599 shares outstanding.

Q: What happened to Ibio Inc’s price movement after its last earnings report?

Ibio Inc reported an EPS of -€0.276 in its last earnings report, beating expectations of -€0.302. Following the earnings report the stock price went up 2.19%.

Q: Which hedge fund is a major shareholder of Ibio Inc?

Currently, no hedge funds are holding shares in DE:0JV0

Compare

0 Followers

0JV0 Stock Chart & Stats

€1.11

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€1.11

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€0.44 - €3.51

Previous CloseN/A

Volume0.00

Average Volume (3M)441.00

Market Cap

$22.57M

Enterprise Value€7.46M

Total Cash (Recent Filing)$4.96M

Total Debt (Recent Filing)$2.93M

Price to Earnings (P/E)―

Beta0.17

Next Earnings

Nov 18, 2025

EPS Estimate

-0.18

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.28

Shares Outstanding20,254,599

10 Day Avg. Volume543

30 Day Avg. Volume441

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)0.54

Price to Sales (P/S)20.03

P/FCF Ratio-0.52

Enterprise Value/Market Cap0.33

Enterprise Value/Revenue19.89

Enterprise Value/Gross Profit6.67

Enterprise Value/Ebitda-0.49

Forecast

1Y Price Target

$3.37

Price Target Upside204.01% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering4

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Ibio News

iBio management to meet with Oppenheimer

Meeting to be held on November 5 hosted by Oppenheimer. Published first on TheFly – the ultimate source...

9d ago

IBIO

iBio price target raised to $6 from $5 at Oppenheimer

Oppenheimer analyst Jay Olson raised the firm’s price target on iBio (IBIO) to $6 from $5 and keeps...

13d ago

IBIO

iBio announces new preclinical data on NHP study of IBIO-1610

iBio (IBIO) announced new preclinical data from its obese non-human primate, NHP, study evaluating IBIO-610, potentially a first-in-class...

13d ago

IBIO

iBio price target raised to $6 from $5 at Oppenheimer

Oppenheimer raised the firm’s price target on iBio (IBIO) to $6 from $5 and keeps an Outperform rating...

14d ago

WVE

IBIO

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...

19d ago

IBIO

NEUP

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...

20d ago

IBIO

NEUP

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...

21d ago

IBIO

Closing Bell Movers: DocGo soars after SteadyMD deal

Stock futures were broadly but marginally higher following sharp regular session gains, as markets exuded a cautiously optimistic...

22d ago

CCK

FLR

iBio initiated with an Outperform at Oppenheimer

Oppenheimer initiated coverage of iBio (IBIO) with an Outperform rating and $5 price target The firm based its...

23d ago

IBIO

iBio initiated with an Outperform at Oppenheimer

Oppenheimer initiated coverage of iBio (IBIO) with an Outperform rating and $5 price target citing “optimism” for lead...

23d ago

IBIO

iBio Regains Nasdaq Compliance with Bid Price Rule

The latest update is out from Ibio ( ($IBIO) ). On November 4, 2025, iBio, Inc. announced that...

8d ago

IBIO

iBio Unveils Promising Preclinical Data for IBIO-610

Ibio ( ($IBIO) ) just unveiled an update. On October 30, 2025, iBio, Inc. announced new preclinical data...

13d ago

IBIO

Ibio Inc’s Future at Risk: Reliance on Third-Party Licenses for Key Product Candidates

Ibio Inc (IBIO) has disclosed a new risk, in the Trade Secrets category. Ibio Inc faces significant business...

2M ago

IBIO

iBio, Inc. Reports Transformative Fiscal Year 2025

Ibio Inc ( ($IBIO) ) has released its Q4 earnings. Here is a breakdown of the information Ibio...

2M ago

IBIO

0JV0 FAQ

What was Ibio Inc’s price range in the past 12 months?

Ibio Inc lowest stock price was €0.44 and its highest was €3.51 in the past 12 months.

What is Ibio Inc’s market cap?

Ibio Inc’s market cap is $22.57M.

When is Ibio Inc’s upcoming earnings report date?

Ibio Inc’s upcoming earnings report date is Nov 18, 2025 which is in 6 days.

How were Ibio Inc’s earnings last quarter?

Ibio Inc released its earnings results on Sep 05, 2025. The company reported -€0.276 earnings per share for the quarter, beating the consensus estimate of -€0.302 by €0.026.

Is Ibio Inc overvalued?

According to Wall Street analysts Ibio Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Ibio Inc pay dividends?

Ibio Inc does not currently pay dividends.

What is Ibio Inc’s EPS estimate?

Ibio Inc’s EPS estimate is -0.18.

How many shares outstanding does Ibio Inc have?

Ibio Inc has 20,254,599 shares outstanding.

What happened to Ibio Inc’s price movement after its last earnings report?

Ibio Inc reported an EPS of -€0.276 in its last earnings report, beating expectations of -€0.302. Following the earnings report the stock price went up 2.19%.

Which hedge fund is a major shareholder of Ibio Inc?

Currently, no hedge funds are holding shares in DE:0JV0

Company Description

Ibio Inc

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with CC-Pharming Ltd. The company is headquartered in Bryan, Texas.

Ibio (0JV0) Earnings & Revenues

Historic Earnings Reports

0JV0 Stock 12 Month Forecast

Average Price Target

€3.37

▲(204.01% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"€6","-1":"-€1","0.75":"€0.75","2.5":"€2.5","4.25":"€4.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5.191497,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€5.19</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.37447305,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€3.37</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.3843992,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€1.38</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.75,2.5,4.25,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.29,1.590115153846154,1.8902303076923077,2.1903454615384614,2.4904606153846154,2.7905757692307693,3.090690923076923,3.390806076923077,3.6909212307692307,3.9910363846153847,4.291151538461539,4.591266692307692,4.8913818461538465,{"y":5.191497,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.29,1.4503440807692307,1.6106881615384616,1.7710322423076925,1.9313763230769232,2.091720403846154,2.252064484615385,2.4124085653846157,2.5727526461538464,2.733096726923077,2.8934408076923077,3.053784888461539,3.2141289692307695,{"y":3.37447305,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.29,1.297261476923077,1.3045229538461538,1.3117844307692308,1.3190459076923078,1.3263073846153846,1.3335688615384615,1.3408303384615385,1.3480918153846155,1.3553532923076923,1.3626147692307693,1.3698762461538463,1.377137723076923,{"y":1.3843992,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.514,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.514,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.514,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.514,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.514,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.514,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.514,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.514,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.514,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.54,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.645,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.65,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.29,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >